Effect of Dulaglutide (LY2189265) on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects.
Phase of Trial: Phase I
Latest Information Update: 29 Mar 2017
At a glance
- Drugs Dulaglutide; Ethinylestradiol/norgestimate
- Indications Diabetes mellitus; Pregnancy
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 29 Mar 2017 Results of pooled analysis from four trials (NCT01458210, NCT01436201, NCT01432938, and NCT01250834) assessing the effect of dulaglutide on PK of digoxin, warfarin, atorvastatin and Ortho-Cyclen and PD of warfarin, published in the Clinical Pharmacokinetics
- 02 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.